News

July 24, 2019

End-To-End CDMO Business Model Roundtable

July 24, 2019
Article > Inside the Trenches: End-To-End CDMOs/CMOs
July 8, 2019

Injectable Combination Product Regulations

July 8, 2019
Webinar > Navigating Injectable Combination Device & Drug Product Regulations: How a Full-Service CDMO Supports Pharma
May 31, 2019

Manufacturing APIs with Asian Supply Chains

May 31, 2019
Podcast > Manufacturing APIs with Asian Supply Chains
May 16, 2019

CordenPharma Expands Peptide Capacity

May 16, 2019
Article > CordenPharma Expands Peptide Capacity to Support Recent Market Trends
May 4, 2019

Flexible Injectable Compounding-Filling

May 4, 2019
Article > Compounding-Filling Provides Compatibility & Flexibility
March 25, 2019

Artificial Intelligence in Healthcare

March 25, 2019
Article > AI in Healthcare - Is the CDMO Industry Ready?
March 13, 2019

Investments & New EU Centres of Excellence

March 13, 2019
Article > Chemistry Today Takes Five Minutes with CBO Dr. Michael Quirmbach before DCAT 2019.
March 13, 2019

Global Business Reports US Biopharmaceuticals 2019

March 13, 2019
Article > Interview with Dr. Michael Quirmbach in Global Business Report's US Biopharmaceutical Report 2019.
January 22, 2019

CDMOs Expand Peptide Offerings

January 22, 2019
Article > CDMOs Expand Capacity to Support Recent Market Trends
November 8, 2018

Inauguration of new Aseptic Fill & Finish Plant

Nov 05, 2018
Event > Inauguration of new Aseptic Fill & Finish Plant at CordenPharma Caponago
October 22, 2018

CordenPharma at CPhI 2018 – Madrid, Spain

October 22, 2018
Event > CordenPharma at CPhI 2018, Stand 7F30 / October 9-11, Madrid, Spain
October 4, 2018

Integration, Construction & Investment

October 4, 2018
Article > Interview with Dr. Michael Quirmbach, Chief Business Officer, CPI
July 3, 2018

Continuous Production Offers Best Practice for Acasti

Jul 03, 2018
Article > Out of the Sea and into the Factory for Acasti’s Heart Drug Ingredient
July 3, 2018

Targeted APIs & The Future of Manufacturing

Jul 03, 2018
Article > Interview with Dr. Michael Quirmbach, Chief Business Officer, CPI
May 3, 2018

Targeted Cancer Drugs Reshape Drug Manufacturing

May 03, 2018
Article > Parenteral Drug Manufacturing Panel Discussion